IL18 and coronary artery disorder: To our knowledge, this is an update study focused on the association between IL-18 promoter polymorphisms and CAD risk, but it was the first meta-analysis evaluating the potential association of these two IL-18-related polymorphisms and the risk of MI and the number of stenotic coronaries.